Autonomix Medical(US:AMIX) Globenewswire·2025-12-18 13:30Company Overview - Autonomix Medical, Inc. is a medical device company focused on advancing innovative technologies for diagnosing and treating diseases involving the nervous system [3] - The company's first-in-class platform system technology includes a catheter-based microchip sensing array designed to detect and differentiate neural signals with greater sensitivity than existing technologies [3] - The technology aims to enable transvascular diagnosis and treatment of peripheral nervous system diseases throughout the body [3] Product Development - The initial focus of the technology is on pain treatment, specifically targeting pancreatic cancer, which is known for causing severe pain and lacks reliable treatment options [4] - The technology has the potential to address a wide range of indications, including cardiology, hypertension, and chronic pain management [4] - The technology is currently investigational and has not yet received marketing clearance in the United States [4] Upcoming Presentation - Autonomix announced that its abstract has been accepted for poster presentation at the 2026 ASCO Gastrointestinal Cancers Symposium [1] - The presentation will focus on a long-term analysis of pain mitigation in pancreatic adenocarcinoma through denervation via transvascular RF energy-based ablation [1] - The poster session is scheduled for January 9, 2026, with specific time slots for presentation [1]